Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 12:03 pm Purchase | 13G | GILEAD SCIENCES INC GILD | Capital Research Global Investors | 85,132,885 6.7% | 12,584,096 (+17.35%) | View |
| 2020-02-12 09:23 am Purchase | 13G | GILEAD SCIENCES INC GILD | VANGUARD GROUP INC | 103,771,848 8.2% | 3,357,598 (+3.34%) | View |
| 2020-02-10 5:24 pm Purchase | 13G | SIERRA ONCOLOGY INC SRRA | GILEAD SCIENCES INC. GILD | 1,073,300 9.99% | 1,073,300 (New Position) | View |
| 2020-02-05 11:45 am Purchase | 13G | GILEAD SCIENCES INC GILD | BlackRock Inc. BLK | 106,473,594 8.4% | 2,287,517 (+2.20%) | View |
| 2019-11-01 4:36 pm Purchase | 13D | GALAPAGOS NV SPONSORED ADR GLPG | GILEAD SCIENCES INC. GILD | 20,628,929 29.9% | 7,039,243 (+51.80%) | View |
| 2019-08-29 1:56 pm Purchase | 13D | GALAPAGOS NV SPONSORED ADR GLPG | GILEAD SCIENCES INC. GILD | 13,589,686 22% | 6,828,985 (+101.01%) | View |
| 2019-07-23 5:11 pm Unchanged | 13D | GALAPAGOS NV SPONSORED ADR GLPG | GILEAD SCIENCES INC. GILD | 6,760,701 12.3% | 0 (Unchanged) | View |
| 2019-05-03 3:31 pm Purchase | 13G | HOOKIPA PHARMA INC HOOK | GILEAD SCIENCES INC. GILD | 1,667,268 7.7% | 1,667,268 (New Position) | View |